Home›Stock Screener›Corona Remedies›P/E Ratio

Corona Remedies P/E Ratio

Current P/E Ratio
64.67
High Valuation
Very High - High growth expectations or significantly overvalued

Corona Remedies (CORONA) P/E ratio is 64.67 (High), EPS (TTM) ₹30.27, current price ₹2119.40 on NSE vs historical average P/E of 51.35 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Read CORONA dividend track record for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/E Ratio 64.67
Current Price ₹2119.40
EPS (TTM) ₹30.27
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 51.35
Historical Range 51.35 - 51.35
Percentile 100.0%

Sector Context

Sector Average 55.43
Sector Median 30.43
Sector Rank #11 of 195
Sector Percentile 5.6%

Earnings Breakdown (TTM)

TTM EPS ₹30.95
Mar 2026 ₹7.41
Jun 2026 ₹9.83

CORONA P/E Ratio — Valuation Signal & Historical Context

Corona Remedies P/E 64.67 vs historical average 51.35, range 51.35–51.35 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Corona Remedies stock price NSE.

  • Stock appears overvalued with PE of 64.67, suggesting caution for new investments
  • Current PE is 25.9% above historical average
  • Trading at premium to sector average PE of 55.43

Corona Remedies P/E Ratio Historical Trend

CORONA annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 64.67 vs historical average 51.35. See CORONA P/B ratio history to compare market price against book value per share.

CORONA Historical P/E Ratio — EPS, Year-End Price & Valuation

Corona Remedies annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 51.35 28.01 ₹1438.40 NSE High

CORONA vs Healthcare Peers — P/E Ratio Comparison

Corona Remedies P/E 64.67 vs Healthcare average 55.43, median 30.43 — range 2.86–712.0.

Sector Average
55.43
Sector Median
30.43
Lowest P/E
2.86
Highest P/E
712.0
Companies
195
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.29 ₹53 Low
Colinz Laboratories COLINZ 3.6 ₹10 Low
Sun Pharma Advanced Rese… SPARC 4.05 ₹6,404 Low
Sunrest Lifescience SUNREST 4.08 ₹65 Low
Shelter Pharma SHELTER 4.85 ₹44 Low
GKB Ophthalmics GKB 5.94 ₹33 Low
JFL Life Sciences JFLLIFE 6.44 ₹86 Low
Dipna Pharmachem DPL 6.52 ₹18 Low
Royal Sense ROYAL 7.11 ₹51 Low